People: Biosig Technologies Inc (BSGM.OQ)

BSGM.OQ on NASDAQ Stock Exchange Capital Market

23 Sep 2019
Change (% chg)

$-0.06 (-0.73%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Londoner, Kenneth 

Mr. Kenneth L. Londoner is Executive Chairman of the Board, Chief Executive Officer of the Company. He has served as our director since February 2009, as our executive chairman since November 2013 and our chief executive officer since July 2017. He previously served as our chairman and chief executive officer from February 2009 to September 2013. Mr. Londoner has served as the managing partner of Endicott Management Partners, LLC, a firm dedicated to assisting emerging growth companies in their corporate development, since February 2010. From April 2007 to October 2009, he served as executive vice president – corporate business development and senior director of business development and, from November 2009 to December 2010, he served as a consultant to NewCardio, Inc., a medical device designer and developer. Mr. Londoner also served as a director of chatAND Inc. from January 2012 to April 2015. Mr. Londoner is a co-founder and board member of Safe Ports Holdings, Charleston, South Carolina. Mr. Londoner also served as a director of MedClean Technologies, Inc. from November 2008 to September 2010. Mr. Londoner was an investment officer and co-manager of the Seligman Growth Fund, Seligman Capital Fund, and approximately $2 billion of pension assets at J & W Seligman & Co, Inc. in New York from 1991 to 1997. Mr. Londoner graduated from Lafayette College in 1989 with a degree in economics and finance and received his MBA from New York University’s Leonard N. Stern School of Business in 1994.We believe that Mr. Londoner’s extensive experience in financial and venture capital matters, as well as his intimate knowledge of our company as its co-founder make him an asset to our board of directors.

Basic Compensation

Total Annual Compensation, USD 854,167
Restricted Stock Award, USD 1,381,800
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 2,235,970

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --